CURE retained OWC to educate the market on its innovative drug delivery platform, a thin film much like a Listerine breath strip, so patients don’t have to swallow pills, increasing the absorption in the body and reducing toxicity. OWC was to raise CURE’s profile among pharmaceutical companies, investors and potential partners. OWC developed a campaign to create awareness for CURE’s proprietary delivery technologies, pioneering research and partnerships in the sector. OWC secured coverage in key pharma, biotech, healthcare and financial trades, as well as key business outlets. The success resulting from OWC’s campaigns created new business opportunities, attracted the attention from potential partners and solidified its relationship with investors and advisors.
OWC raised the visibility of CURE leadership by securing several bylined articles in pharmaceutical trades.
OWC worked closely with key financial publications that influence markets including The Rose Sheet, Proactive Investors and The Wall Street Transcript. OWC connected reporters with partners, key executives and background information to ensure stories accurately position the company.
San Fernando Valley is packed with pharma companies, so standing out in this crowded market is challenging. OWC built relationships with key local reporters, conducting facility tours and providing access to content to build compelling stories.
OWC created media opportunities at every tradeshow and conference to ensure ROI on every dollar spent by securing background briefings and on-camera interviews with media and bloggers.
CURE Pharmaceutical has become the go-to partner for pharmaceutical drug delivery tech in the cannabis industry, even being included for the first time in the global oral thin film drugs market analyst report by Market Research Future (MRFR) along the industry heavy-weights Pfizer Inc., Johnson & Johnson Services, Inc., Novartis AG and GlaxoSmithKline Plc.
In-depth features of CURE’s buccal oral thin film technology ran in key trade publications such as Drug Development and Delivery and PharmaVOICE, which are two key outlets for CURE.
Coverage in local publications such as San Fernando Valley Business Journal and The VC Star (part of the USA Today network) raised CURE’s local profile in an Amgen dominated area, attracting new talent in the form of three new executive hires and three Board of Director additions this year.
As a direct result of OWC’s campaign, new business opportunities and partnerships have developed with top cannabis companies for medical development.